JL Medi Labs (제이엘메디랩스)
Seoul, South Korea
JL Medi Labs develops technology to diagnose diseases by simultaneously detecting various biomarkers with high sensitivity based on the analysis power of a small amount of blood. The company is developing a kit for early diagnosis of gastric, colorectal and lung cancer by fusing single-molecule FRET and ultra-high-resolution fluorescence microscopy technology with enzyme immunoassay (ELISA), which is considered a standard technology for protein biomarker diagnosis.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- jlmedilabs.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of JL Medi Labs (제이엘메디랩스)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now